AKT1 and colorectal carcinoma: Notably, the inhibitory effects of metformin on CRC have been reported in vitro, where metformin-treated CRC cells expressed several miRNAs and mRNAs involved in cell metabolism and PI3K-Akt–MAPK/ERK signaling pathways [33].